Trials / Completed
CompletedNCT03360656
Transnasal Induction of Normothermia in Febrile Stroke Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- CoolTech LLC · Industry
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate safety and performance of the COOLSTAT® Transnasal Thermal Regulating Device in reducing temperature in a population of febrile subjects who meet the inclusion/exclusion criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transnasal Thermal Regulating Device | Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 8 to 24 hours |
Timeline
- Start date
- 2018-01-16
- Primary completion
- 2022-04-22
- Completion
- 2022-04-22
- First posted
- 2017-12-04
- Last updated
- 2023-06-18
- Results posted
- 2023-06-18
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03360656. Inclusion in this directory is not an endorsement.